论文部分内容阅读
休斯敦消息:据布法罗市罗斯韦尔·帕克纪念研究所的临床妇产肿瘤学主任Steven Pi-ver报告,用放射和羟基脲联合治疗宫颈癌,可使此癌的年死亡率下降50%,宫颈癌患者的五年存活率已提高到94%。他在此地召开的美国临床肿瘤学会会议上提出罗斯韦尔·帕克设计评价的羟基脲的放射增强性质的三项研究结果,并进行了评价。 Piver说,近25年来,随着高能量大伏特的技术和放射治疗的进展,但单用放射疗法治疗子宫颈癌,患者的存活率并未得到提高。到目前为止,报道单用骨盆照射治疗患ⅡB期宫颈癌的妇女,最高五年存活率是45～60%。接
Houston: According to Steven Piver, director of clinical obstetrics and oncology at the Roswell Park Memorial Institute in Buffalo, radiation and urea combined with cervical cancer can reduce the annual mortality rate of this cancer by 50%. The five-year survival rate of patients with cervical cancer has been increased to 94%. At the conference of the American Society of Clinical Oncology, he presented the results of three studies evaluating the radio-enhanced properties of hydroxyurea that Roswell Parker designed and evaluated. Piver said that in the past 25 years, with the development of high-energy and large-volume technologies and radiation therapy, the survival rate of patients with cervical cancer alone has not been improved. So far, it has been reported that women who have stage IIB cervical cancer treated with pelvic irradiation alone have a maximum five-year survival rate of 45 to 60%. Pick up